

(Alliance News) - Arix Bioscience PLC said on Monday its net asset value at January 31 was 180 pence, down from 182p at the end of October, 2022.


(Alliance News) - Arix Bioscience PLC on Friday said that its portfolio company has completed a previously announced merger with Gemini Therapeutics I...


Arix Bioscience PLC - London-based venture capital investor in biotech firms - Chair Peregrine Moncreiffe buys 78,000 shares at GBP1.04 each, worth GB...


(Alliance News) - Arix Bioscience PLC on Friday said its portfolio company Imara Inc has signed a merger deal with Enliven Therapeutics Inc.


(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and last week and ...


Arkle Resources PLC - Ireland-based gold and zinc explorer - Says that Group Eleven Resources Corp, its partner and operator for the Stonepark project...


(Alliance News) - Arix Bioscience PLC on Thursday reported a decline in net asset value as public biotech markets did not perform well.